A novel assay measures ornithine decarboxylase activity in high-throughput screenings, indicating its potential for broader applications.
Ornithine decarboxylase (ODC) catalyzes the first committed step in polyamine biosynthesis and plays a central role in cellular growth and proliferation.Quantitative analysis of ODC activity has traditionally relied on radiometric or coupled-enzyme assays, which limit scalability and accessibility.Here, we report on the development of DAB-ODC, a fluorescence-based assay that enables direct, sensitive, and high-throughput quantification of ODC activity by detecting putrescine through its reaction with 1,2-diacetylbenzene (DAB).Using purified recombinant ODC from Saccharomyces cerevisiae and humans, we show that DAB-ODC supports measurement of enzyme activity and accurate determination of steady-state kinetic parameters.Inhibition studies with the inhibitor DL--difluoromethylornithine (DFMO) and three recently reported DFMO analogs yielded IC values consistent with those obtained using established orthogonal assays.All enzymatic measurements were validated by thin-layer chromatography.Assay performance metrics, including coefficient of variation (CV), Z factor, and signal-to-background ratios, demonstrate compatibility with large-scale chemical screening.Together, these results establish DAB-ODC as a versatile platform for ODC enzymology, inhibitor profiling, and high-throughput interrogation of polyamine metabolism.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: